Malaria is a constant threat for nearly half of the world’s population, and people who travel to those areas are also at risk. Although the short-term side effects of prophylactic drugs are ...

A new approach to antimalarial development, aided by high-throughput screening, could help to overcome resistance.

Scientists from Drexel University’s College of Medicine and Columbia University’s Irving Medical Center have uncovered a crucial structural feature of a key malaria drug target, known as PfATP4, and ...

In a fresh approach to blocking transmission of the malaria parasite by mosquitoes, potent antimalarial compounds that kill parasites in mosquitoes are incorporated into bed-net prototypes. Exposure ...